Glycemic Status and Metformin's Effects on RBC Indices in Diabetes
Journal name: The Malaysian Journal of Medical Sciences
Original article title: The Impact of Glycemic Status and Metformin Administration on Red Blood Cell Indices and Oxidative Stress in Type 2 Diabetic Patients
The Malaysian Journal of Medical Sciences (MJMS) is a peer-reviewed, open-access journal published online at least six times a year. It covers all aspects of medical sciences and prioritizes high-quality research.
This page presents a generated summary with additional references; See source (below) for actual content.
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
Adel Abdel-Moneim, Eman Salah Abdel-Reheim, Margit Semmler, Wessam Addaleel
The Malaysian Journal of Medical Sciences:
(A peer-reviewed, open-access journal)
Full text available for: The Impact of Glycemic Status and Metformin Administration on Red Blood Cell Indices and Oxidative Stress in Type 2 Diabetic Patients
Year: 2019 | Doi: 10.21315/mjms2019.26.4.6
Copyright (license): CC BY 4.0
Download the PDF file of the original publication
Summary of article contents:
Introduction
Diabetes mellitus, particularly type 2 diabetes (T2DM), is a significant global health issue linked to increased cardiovascular disease risks. The prevalence of T2DM is rapidly growing, with projections suggesting that nearly 592 million individuals will be affected by 2035. Metformin is regarded as the first-line treatment for T2DM, known for improving glycemic control and reducing oxidative stress. This study aimed to evaluate the effects of metformin administration on red blood cell (RBC) indices and oxidative stress levels in T2DM patients, in light of its role as both a therapeutic agent and a potential contributor to anemia.
Effects of Metformin on Red Blood Cell Indices
The study revealed that metformin treatment improved oxidative stress and glycemic status but was associated with a significant reduction in hemoglobin concentration across all treated groups. There was a marked increase in red cell distribution width (RDW) among diabetic individuals, indicating heightened variability in RBC size, which is often associated with inflammatory processes. While oxidative stress markers, such as malondialdehyde (MDA), were elevated and reduced glutathione (GSH) levels were low in diabetic patients, the results emphasized that metformin's influence on hemoglobin levels suggests the development of metformin-induced anemia, independent of diabetes-related complications.
Conclusion
In conclusion, this study highlights the dual role of metformin as an effective antidiabetic medication that simultaneously poses a risk for anemia in T2DM patients. Despite its beneficial effects on glycemic control and reduced oxidative stress, the noticeable decrease in hemoglobin levels across treatment groups indicates the need for additional monitoring and management of potential anemia in patients undergoing metformin therapy. Such findings could prompt further research on the mechanisms underlying this phenomenon, as well as the necessity for routine screenings and possible interventions to mitigate the impact of anemia in diabetic patient populations.
FAQ section (important questions/answers):
What is the primary focus of the study on metformin?
The study aimed to assess the effects of metformin on glycemic status, red blood cell (RBC) indices, and oxidative stress in patients with type 2 diabetes mellitus.
How were participants categorized in the metformin study?
Participants were divided into seven groups, including healthy controls and diabetic patients receiving various treatments such as metformin alone, glimepiride, and combinations of these medications.
What were the significant findings related to RBC indices?
The study found that hemoglobin concentrations decreased significantly among all diabetic groups, while red cell distribution width (RDW) was significantly elevated, indicating poor erythrocyte health.
What conclusions were drawn about metformin-induced anemia?
The study concluded that metformin administration improves oxidative stress and glycemic control but leads to decreased hemoglobin levels, indicating that metformin-induced anemia is independent of diabetic complications.
Glossary definitions and references:
Scientific and Ayurvedic Glossary list for “Glycemic Status and Metformin's Effects on RBC Indices in Diabetes”. This list explains important keywords that occur in this article and links it to the glossary for a better understanding of that concept in the context of Ayurveda and other topics.
1) Table:
A table in scientific literature serves as a methodical arrangement of data. It visually presents quantitative and qualitative information, allowing researchers to easily interpret complex datasets. Tables often accompany results in studies, summarizing statistical comparisons and highlighting significant findings, thus aiding in drawing conclusions and facilitating comparison across participant groups.
2) Blood:
Blood is a vital bodily fluid responsible for transporting oxygen, nutrients, hormones, and waste products between different tissues and organs. In the context of diabetes and other diseases, blood samples are frequently analyzed to measure levels of glucose, hemoglobin, and various biomarkers, thus providing crucial insights into patient health and disease management.
3) Study (Studying):
A study systematically investigates a particular phenomenon, often involving data collection, analysis, and interpretation within a defined framework. In medical research, studies provide evidence for understanding diseases, treatment effectiveness, and patient outcomes. They can be observational, clinical, or experimental, each contributing unique insights to the broader field of health science.
4) Inflammation:
Inflammation is an immune response characterized by redness, swelling, heat, and pain, often arising from injury or infection. Chronic inflammation plays a significant role in the development and progression of various diseases, including diabetes. It is typically assessed by measuring biomarkers and is integral to understanding conditions like cardiovascular disease and metabolic disorders.
5) Disease:
Disease refers to a pathological condition marked by specific symptoms and signs, often caused by external factors (e.g., infections) or internal dysfunctions (e.g., genetic disorders). In diabetes research, understanding diseases and their interconnections with lifestyle factors, treatment protocols, and other comorbidities is crucial for developing effective management strategies and improving patient outcomes.
6) Rules:
Rules are established guidelines that govern conduct or processes. In scientific research, rules may pertain to ethical standards, methodological approaches, and statistical analyses. Adherence to scientific rules ensures the reliability and validity of research findings, ultimately contributing to the integrity of data interpretation and application in clinical practice.
7) Pur:
The term poor refers to inadequate condition or quality. In medical contexts, poor health outcomes may signify ineffective management of diseases or complications arising from conditions like diabetes. The phrase 'poor glycemic control' reflects ineffective blood sugar management, increasing the risk of complications and emphasizing the need for vigilant monitoring and intervention.
8) Male:
Male refers to the biological sex characterized by specific reproductive anatomy and hormonal profiles. In clinical studies, gender differences often play a crucial role in research outcomes, influencing disease prevalence, symptomology, and treatment responses. Understanding male-specific responses is essential for personalized medicine and effective health interventions in diabetes management.
9) Measurement:
Measurement is the process of quantifying observations to derive meaningful insights. In scientific studies, accurate measurement of variables—such as blood glucose levels, biomarkers like hemoglobin A1c, and patient demographics—is critical. Proper measurement ensures data integrity, informs clinical decisions, and forms the evidence base for establishing treatment guidelines.
10) Observation:
Observation is the act of closely monitoring phenomena to gather empirical data. In clinical studies, observation may involve tracking patient responses to treatment, disease progression, and lifestyle changes. Rigorous observational data contribute to scientific knowledge, enhance understanding of disease dynamics, and inform preventative measures in healthcare.
11) Bhatnagar:
Bhatnagar is a surname that often identifies specific researchers or contributors in medical literature. In this context, it could refer to an author involved in the study of diabetes, potentially contributing to discussions on the complexities of disease progression and treatment strategies. Literature associated with Bhatnagar may include insights on various health metrics.
12) Sanchi:
Sanchi might refer to an attribution to a researcher whose work applies to diabetes studies or related fields. Investigations led by individuals named Sanchi could contribute critical findings on diabetes management, potentially focusing on therapeutic approaches or health metrics connected to diabetes prevalence and treatment efficacy.
13) Family:
Family can encompass genetic, social, or support structures significantly impacting health. In diabetes research, a family history of diabetes may elevate an individual's risk for developing the condition, highlighting the importance of understanding genetic predisposition and familial environmental factors in promoting preventative strategies and tailored interventions.
14) Sharman (Sarma, Sharma, Sarman):
Sharma is likely the surname of a researcher contributing to studies on diabetes or related health issues. Research authored or co-authored by individuals named Sharma may provide valuable insights on the correlation between diabetes, oxidative stress, and associated health metrics, aiding in the broader understanding of chronic conditions.
15) Nature:
Nature often refers to the inherent characteristics of biological entities or the natural world. In scientific literature, it can denote the biological underpinnings of diseases, ecological impacts on health, or principles governing biological processes. It emphasizes the connection between environmental factors and health outcomes, especially in complex diseases like diabetes.
16) Indian:
Indian may denote research conducted in India or relating to the health characteristics of Indian populations. Understanding regional health metrics is essential in diabetes research, as lifestyle, dietary habits, and genetic predispositions vary significantly across populations. Research focused on Indian contexts provides unique insights into diabetes prevalence and management.
17) Honey:
Honey is a natural substance often studied for its health properties. In the context of diabetes, honey may be examined for its role as a sweetener with potential health benefits or adverse effects on blood sugar levels. Research may explore honey's antioxidant properties and its impact on diabetes management and oxidative stress.
18) Akta:
Akta may refer to a researcher or author contributing to diabetes-related literature. Published work by individuals named Akta might explore innovative approaches to diabetes management, treatment interventions, and the implications of various health metrics, enriching the discourse and understanding of diabetes pathology.
19) Sign:
Sign denotes an observable condition or indicator. In medical contexts, signs may refer to clinical measurements like glycemic control markers. Understanding the significance of signs in diabetes—such as elevated HbA1c levels or specific symptoms—helps clinicians diagnose, monitor disease progression, and establish treatment plans tailored to individual patient needs.
20) Line:
Line may encompass discussions about treatment protocols or management approaches in diabetes. It often refers to first-line treatments, the primary options healthcare providers recommend when treating diabetes patients. These lines of treatment are crucial in establishing effective management strategies and improving clinical outcomes in diabetic patients.
21) Hand:
In medical literature, hand may refer to practical applications of research findings or interventions. It often signifies the importance of providing a practical touch to theoretical knowledge, such as incorporating patient-centered approaches in diabetes management that ensure comprehensive care addressing both clinical and personal health needs.
22) Post:
In scholarly literature, post may refer to the aftermath of an intervention or the outcomes following a specific treatment. Evaluating post-treatment results—such as the effects of metformin on diabetic patients—provides insights into efficacy, demonstrating the compound's impact on various health parameters related to diabetes.
23) Drug:
Drug indicates a biochemical substance used for medical treatment. In the context of diabetes, drugs like metformin and glimepiride are pivotal in managing blood glucose levels. Investigating the effects, side effects, and interactions of these drugs is essential for optimizing patient treatment regimens and dictating health outcomes.
24) Tata:
Dada is potentially a reference to a researcher or author in the field of diabetes. Contributions from individuals named Dada may help shape the scientific discourse surrounding diabetes research, focusing on aspects like treatment outcomes, disease mechanisms, and novel interventions aimed at improving patient care and diabetes management.
25) Discussion:
Discussion in scientific literature critically examines research findings, exploring implications and connections to existing knowledge. This section allows researchers to analyze results, hypothesize about underlying mechanisms, and propose future research pathways. In diabetes studies, discussion helps contextualize findings and advocate for effective management strategies to improve patient health.
26) Reflecting:
Reflecting indicates contemplation on the implications of findings in research. In medical studies like those involving diabetes, reflecting on results allows researchers to understand the broader impact of their data on treatment strategies and patient outcomes. This critical analysis fosters continuous improvement in diabetes management approaches.
27) Pregnant:
Pregnant refers to the state of being expectant, which may have implications for diabetes management. Gestational diabetes is a significant concern during pregnancy, requiring attention to blood sugar levels and dietary adjustments. Understanding the interplay between pregnancy and diabetes is crucial for providing maternal and fetal health care.
28) Species:
Species indicates distinct biological groups, often examined in epidemiological studies to understand disease prevalence and treatment responses. In diabetes research, examining variations across species, including humans and animals, aids in developing effective therapies and enhancing knowledge about metabolic pathways and their implications for diabetes management.
29) Science (Scientific):
Science encompasses the systematic study of the natural world through observation and experimentation. In diabetes research, scientific methods are employed to investigate disease mechanisms, therapeutic interventions, and health outcomes, facilitating the development of evidence-based practices that improve patient care and enhance understanding of complex conditions.
30) Egypt:
Egypt may signify the geographic context of a particular study on diabetes, reflecting regional health metrics, dietary habits, and genetic backgrounds. Understanding diabetes dynamics in Egypt allows for tailored intervention strategies and can provide insights that are culturally relevant, improving the effectiveness of treatment plans in similar populations.
31) Water:
Water is essential for life and crucial for physiological functions. In diabetes management, hydration plays a vital role as it influences blood sugar levels and metabolic processes. Research on the relationship between water intake and diabetes underscores the importance of proper hydration in controlling and managing the condition effectively.
32) Food:
Food represents the nutrients and substances consumed by individuals, directly impacting metabolic processes. In diabetes management, dietary choices significantly influence blood sugar control and overall health. Understanding the relationship between food intake, nutrition, and glycemic control is essential for developing effective dietary interventions and promoting healthier lives in diabetic patients.
Other Health Sciences Concepts:
Discover the significance of concepts within the article: ‘Glycemic Status and Metformin's Effects on RBC Indices in Diabetes’. Further sources in the context of Health Sciences might help you critically compare this page with similair documents:
Inflammation, Blood flow, Chronic disease, Red blood, Anemia, Insulin, Diabetes mellitus, Chronic inflammation, Statistical analysis, Vitamin B12 deficiency, Long-term use, Healthy subjects, Inclusion criteria, Exclusion criteria, Insulin resistance, Oxidative stress, Demographic Data, LDL cholesterol, Study design, Combination therapy, Cardiovascular disease, Endothelial dysfunction, Lipid peroxidation, Health guidelines, Type 2 Diabetes Mellitus, C-Reactive Protein, Type 2 diabetes, HbA1c, Diabetic Nephropathy, Glycemic control, Reduced glutathione, Inflammatory process, Chronic inflammatory process, Vitamin B12, Erythropoiesis, Significant decrease, Hemoglobin concentration, Diabetic neuropathy, Antioxidant, Renal tubules, Microalbuminuria, Correlation coefficient, Oxidative status, Insulin sensitivity, Glibenclamide, Metformin, Inflammatory cytokines, Microvascular complications, Blood glucose, Non-significant changes, Chronic inflammatory disease, Microangiopathy, First line treatment, Triglyceride, Diabetic Complication, Inflammatory disease, Glimepiride, Malondialdehyde concentration, Dual therapy, Diabetic patient, Antioxidant defense system, Antioxidant enzyme, Diabetic group, Metformin treatment, Tissue injury, Lipid peroxidation status, Hematological indices, Red Blood Cell, Antidiabetic agent, Blood cell, Blood glutathione, Metformin therapy, Oral antidiabetic agent, Blood sample, Glycemic status, Non-enzymatic glycosylation, Type 2 diabetic patients, Erythropoietin, Pearson correlation coefficient, Metformin monotherapy, T2DM patients, Anemia in diabetes, Anti-diabetic treatment, Biochemical Measurement, Red cell distribution width, MCH, Red blood cell indices, Patients treated, HbA1C level, RBCs Count, GSH LEVEL, Laboratory assays, Clinical practice guideline, Oxidative stress status, MDA concentration, Metformin treated group, Hb concentration, HCT, MCV, MCHC, Glycemic target, Erythrocyte osmotic fragility, Type 2 diabetic, T2DM, GSH, Metformin administration, Red cell distribution, Microvascular complications of diabetes, Erythrocyte, Hb.